Limited application period for dithranol in psoriasis. Preliminary report on penetration and clinical efficacy.
This preliminary study suggests that a I h application of dithranol may be effective in the treatment of psoriasis. It is conceivable that short application periods for other topically applied agents, e.g. corticosteroids, may reduce the side-effects in non-affected skin, while maintaining the therapeutic benefit in diseased areas.
D000287:Administration, Topical; D000873:Anthracenes / Q000008:administration & dosage*; D000875:Anthralin / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D011565:Psoriasis / Q000188:drug therapy*; D013997:Time Factors
D000873:Anthracenes; D000875:Anthralin